Comparison of steady state femoral head penetration rates between two highly cross-linked polyethylenes in total hip arthroplasty.
ABSTRACT Given that the manufacture of highly cross-linked polyethylene (HXLPE) is not standardized, the behavior of these materials may vary. Our study compares minimum 5-year steady state femoral head penetration rates using the Martell method, in 2 HXPLEs produced by different manufacturers. Patients received a primary hip arthroplasty using an uncemented acetabular component with an HXLPE liner and a 28-mm femoral head. Forty-seven patients in group A received an HXLPE liner (Reflection XLPE, Smith and Nephew Inc, Memphis, Tenn), and 36 patients in group B received a different HXLPE liner (Longevity, Zimmer Inc, Warsaw, Ind). Average follow-up was 6.42 years in group A and 7.64 years in group B. The steady state head penetration rates were not significantly (P > .05) different between the HXPLE groups over the midterm with 0.026 mm/y and 0.025 mm/y in groups A and B, respectively.
- SourceAvailable from: Birgitte Espehaug[show abstract] [hide abstract]
ABSTRACT: This randomized study was performed to compare wear and migration of five different cemented total hip joint articulations in 150 patients. The patients received either a Charnley femoral stem with a 22.2 mm head or a Spectron EF femoral stem with a 28 mm head. The Charnley articulated with a γ-sterilized Charnley Ogee acetabular cup. The Spectron EF was used with either EtO-sterilized non-cross-linked polyethylene (Reflection All-Poly) or highly cross-linked (Reflection All-Poly XLPE) cups, combined with either cobalt chrome (CoCr) or Oxinium femoral heads. The patients were followed with repeated RSA measurements for 2 years. After 2 years, the EtO-sterilized non-cross-linked Reflection All-Poly cups had more than four times higher proximal penetration than its highly cross-linked counterpart. Use of Oxinium femoral heads did not affect penetration at 2 years compared to heads made of CoCr. Further follow-up is needed to evaluate the benefits, if any, of Oxinium femoral heads in the clinical setting. The Charnley Ogee was not outperformed by the more recently introduced implants in our study. We conclude that this prostheses still represents a standard against which new implants can be measured.Journal of Orthopaedic Research 02/2011; 29(8):1222-9. · 2.88 Impact Factor
- [show abstract] [hide abstract]
ABSTRACT: Highly crosslinked polyethylene (HXLPE) was introduced to reduce wear and osteolysis in total joint arthroplasty. While many studies report wear and osteolysis associated with HXLPE, analytical techniques, clinical study design and followup, HXLPE formulation and implant design characteristics, and patient populations differ substantially among investigations, complicating a unified perspective. Literature on first-generation HXLPE was summarized. We systematically reviewed the radiographic wear data and incidence of osteolysis for HXLPE in hip and knee arthroplasty. PubMed identified 391 studies; 28 met inclusion criteria for a weighted-averages analysis of two-dimensional femoral head penetration rates. To determine the incidence of osteolysis, we estimated a pooled odds ratio using a random-effects model. Weighted-averages analyses of femoral head penetration rates in HXLPE liners and conventional UHMWPE liners resulted, respectively, in a mean two-dimensional linear penetration rate of 0.042 mm/year based on 28 studies (n=1503 hips) and 0.137 mm/year based on 18 studies (n=695 hips). The pooled odds ratio for the risk of osteolysis in HXLPE versus conventional liners was 0.13 (95% confidence interval, 0.06-0.27) among studies with minimum 5-year followup. We identified two clinical studies of HXLPE in TKA, preventing systematic analysis of outcomes. HXLPE liner studies consistently report lower femoral head penetration and an 87% lower risk of osteolysis. Reduction in femoral head penetration or osteolysis risk is not established for large-diameter (>32 mm) metallic femoral heads or ceramic femoral heads of any size. Few studies document the clinical performance of HXLPE in knees.Clinical Orthopaedics and Related Research 03/2011; 469(8):2262-77. · 2.79 Impact Factor